Physician profile
Jack Xu
NPI 1790239101
$14,391.16
in general payments reported to CMS, 2019-2025
24 companies · $6,436 in 2025
The $6,436 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $225 · 2021: $398 · 2022: $1,209 · 2023: $4,394 · 2024: $1,620 · 2025: $6,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,584 · Food and Beverage: $5,841 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,583.63 |
| Food and Beverage | $5,840.86 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,639.34 | 2021-2025 | Triclip, Mitraclip |
| Heartflow, INC. | $2,678.49 | 2022-2025 | Ffrct |
| Boston Scientific Corporation | $1,746.09 | 2022-2025 | Watchman Access System |
| Novo Nordisk INC | $237.58 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $234.72 | 2020-2024 | Repatha |
| Pfizer INC. | $219.88 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $207.58 | 2022-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $196.28 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.82 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $171.62 | 2021-2024 | Brilinta, Andexxa, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $115.49 | 2022-2024 | Eliquis, Camzyos |
| Siemens Medical Solutions USA, INC. | $113.90 | 2025 | Magnetom Sola |
| Abiomed | $109.04 | 2022 | |
| Merck Sharp & Dohme LLC | $108.31 | 2022 | |
| Edwards Lifesciences Corporation | $97.90 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $69.81 | 2022 | |
| Vital Connect, INC | $58.78 | 2023-2025 | Vitalpatch Rtm |
| Lantheus Medical Imaging, INC. | $41.41 | 2025 | |
| Cleerly, INC. | $27.61 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Cashflow Solutions, LLC | $25.43 | 2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Actelion Pharmaceuticals US, INC. | $25.27 | 2024 | Uptravi, Opsumit |
| Bayer Healthcare LLC | $25.00 | 2025 | |
| Medtronic, INC. | $24.79 | 2025 | Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.02 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.